Company Filing History:
Years Active: 2003
Title: Simon Jeremy Dowell: Innovator in G Protein Research
Introduction
Simon Jeremy Dowell is a notable inventor based in St. Albans, GB. He has made significant contributions to the field of biochemistry, particularly in the development of chimeric G proteins. His innovative work has led to advancements in methods for screening compounds that interact with receptors.
Latest Patents
Simon holds a patent for "G protein chimeras and methods of screening compounds." This patent describes a chimeric G protein that incorporates yeast G (Gpa1p) amino acid sequences modified by a minimum of three amino acid positions within the C-terminal 10 amino acids. The modifications involve substitutions with alternative amino acids. The patent also details a transformed yeast cell that comprises this chimeric G protein and outlines a method for screening compounds that can interact with a receptor. This method involves contacting a compound of interest with the yeast cell and observing either the growth response of the cell or the production of a reporter gene product. Simon has 1 patent to his name.
Career Highlights
Simon Jeremy Dowell has had a distinguished career, working with Glaxo Wellcome Inc., a leading pharmaceutical company. His role at the company has allowed him to focus on innovative research and development in the field of biochemistry.
Collaborations
Simon has collaborated with Andrew James Brown, contributing to the advancement of their shared research interests. Their partnership has fostered a productive environment for innovation and discovery.
Conclusion
Simon Jeremy Dowell is a prominent figure in the realm of G protein research, with a patent that showcases his innovative approach to biochemistry. His work continues to influence the field and pave the way for future discoveries.